发明名称 |
NON-ENDOGENOUS, CONSTITUTIVELY ACTIVATED HUMAN G PROTEIN-COUPLED RECEPTORS |
摘要 |
Disclosed are constitutively activated, non-endogenous versions of endogenous human GPCRs comprising the following amino acid sequence region (C-terminus to N-terminus orientation) and/or the following nucleic acid sequence region (3' to 5' orientation) transversing the transmembrane-6 (TM6) and intracellular loop-3 (IC3) regions of the GPCR:and/orrespectively. In a preferred embodiment, P1 and Pcodon are endogenous proline and an endogenous nucleic acid encoding region encoding proline, respectively, located within TM6 of the non-endogenous GPCR; AA15 and (AA-codon)15 are 15 endogenous amino acid residues and 15 codons encoding endogenous amino acid residues, respectively; and X and Xcodon are non-endogenous lysine and non-endogenous nucleic acid region encoding lysine, respectively, located within IC3 of the non-endogenous GPCR. The purified and isolated non-endogenous human GPCRs having these mutations, and the receptors incorporated into mammalian cells, are well within the present disclosure. |
申请公布号 |
EP1121431(A1) |
申请公布日期 |
2001.08.08 |
申请号 |
EP19990951991 |
申请日期 |
1999.10.12 |
申请人 |
ARENA PHARMACEUTICALS, INC. |
发明人 |
BEHAN, DOMINIC, P.;CHALMERS, DEREK, T.;LIAW, CHEN, W. |
分类号 |
G01N33/50;A61K38/00;A61K45/00;A61P43/00;C07D231/12;C07D231/16;C07D409/12;C07K5/08;C07K7/06;C07K14/705;C07K14/72;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12N15/12;C12N15/16;C12Q1/02;G01N33/15;G01N33/566 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|